Source: The Business Journals: Boston

Biogen: Biogen lays off researchers, focuses on 'external collaborations'

The Cambridge drugmaker said the smaller research organization "will match the needs of a prioritized preclinical portfolio."

Read full article »
Annual Revenue
$5.0-10B
Employees
5.0-10K
Christopher A. Viehbacher's photo - President & CEO of Biogen

President & CEO

Christopher A. Viehbacher

CEO Approval Rating

48/100

Read more